Abstract

During myogenesis, myoblasts fuse into multinucleated myotubes that acquire the contractile fibrils and accessory structures typical of striated skeletal muscle fibers. To support the high energy requirements of muscle contraction, myogenesis entails an increase in mitochondrial (mt) mass with stimulation of mtDNA synthesis and consumption of DNA precursors (dNTPs). Myotubes are quiescent cells and as such down-regulate dNTP production despite a high demand for dNTPs. Although myogenesis has been studied extensively, changes in dNTP metabolism have not been examined specifically. In differentiating cultures of C2C12 myoblasts and purified myotubes, we analyzed expression and activities of enzymes of dNTP biosynthesis, dNTP pools, and the expansion of mtDNA. Myotubes exibited pronounced post-mitotic modifications of dNTP synthesis with a particularly marked down-regulation of de novo thymidylate synthesis. Expression profiling revealed the same pattern of enzyme down-regulation in adult murine muscles. The mtDNA increased steadily after myoblast fusion, turning over rapidly, as revealed after treatment with ethidium bromide. We individually down-regulated p53R2 ribonucleotide reductase, thymidine kinase 2, and deoxyguanosine kinase by siRNA transfection to examine how a further reduction of these synthetic enzymes impacted myotube development. Silencing of p53R2 had little effect, but silencing of either mt kinase caused 50% mtDNA depletion and an unexpected decrease of all four dNTP pools independently of the kinase specificity. We suggest that during development of myotubes the shortage of even a single dNTP may affect all four pools through dysregulation of ribonucleotide reduction and/or dissipation of the non-limiting dNTPs during unproductive elongation of new DNA chains.

Highlights

  • In developing muscle, stimulation of mitochondrial biogenesis and mtDNA expansion occur with downregulation of deoxynucleotide synthesis

  • We individually down-regulated p53R2 ribonucleotide reductase, thymidine kinase 2, and deoxyguanosine kinase by siRNA transfection to examine how a further reduction of these synthetic enzymes impacted myotube development

  • When shifted to DM deprived of growth factors and mitogens, C2C12 myoblasts rapidly stop proliferating and initiate a differentiation program leading to their fusion into myotubes that after 4 to 8 days manifest spontaneous twitching

Read more

Summary

Background

Stimulation of mitochondrial biogenesis and mtDNA expansion occur with downregulation of deoxynucleotide synthesis. We individually down-regulated p53R2 ribonucleotide reductase, thymidine kinase 2, and deoxyguanosine kinase by siRNA transfection to examine how a further reduction of these synthetic enzymes impacted myotube development. Two partially overlapping pathways produce dNTPs: (i) cytosolic de novo synthesis with ribonucleotide reduction as a rate-limiting step and (ii) salvage of deoxynucleosides by kinases distributed between the cytosol and mitochondria (Fig. 1) [5] This enzyme network is more active when the need for dNTPs is highest, i.e. during nuclear DNA replication [6]. We have chosen cultures of C2C12 murine myoblasts to study how the enzyme network regulating dNTP synthesis changes during the initial phases of myogenesis and how a down-regulation of enzymes involved in mtDNA depletion syndromes affects the differentiation of myotubes and the expansion of mtDNA. We suggest that shortage of either pyrimidine (TK2 silencing) or purine (dGK silencing) dNTPs interferes with the allosteric regulation of ribonucleotide reduction and/or leads to repeated initiation of abortive DNA molecules, with dissipation of the non-limiting dNTPs

EXPERIMENTAL PROCEDURES
Evaluation of Myogenic Differentiation
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.